Accueil   Diary - News   All news Alizé Pharma reports positive results

Alizé Pharma reports positive results

Alizé Pharma SAS, an Alizé Pharma group company specialized in the development of biopharmaceuticals to treat metabolic disorders and rare diseases, announces today the completion of a Phase Ib trial for AZP-531 in 36 Type 2 Diabetes (T2D) patients. This trial was the last stage in an overall Phase I program performed in 112 healthy volunteers, obese subjects and T2D patients.

 

 

Read the press release